Bio-Techne Corporation (NASDAQ:TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities today announced a partnership with MedSanTek. Under the agreement, MedSanTek becomes the distributor of Bio-Techne's R&D Systems, Novus, Tocris, Protein Simple, Advanced Cell Diagnostics (ACD), and Asuragen brands across Turkey.

Founded in the late 2000s, MedSanTek is a leading in vitro diagnostics and research products distributor, serving Turkey and Azerbaijan. Partnering with global brands, the company provides high-quality solutions in molecular biology, immunology, cancer research, cell therapy, and more, earning a reputation for innovation and customer satisfaction in advancing science and healthcare.